胃腸內視鏡狹窄治療設備 - 全球市場考量、競爭格局、市場預測（2030 年）

預計 2024 年至 2030 年預測期內，全球胃腸內視鏡狹窄治療設備市場將以 5.36% 的複合年增長率成長。 由於結腸癌、直腸癌、食道癌、胃食道逆流（GERD）和腸躁症（IBS）等各種胃腸道（GI）疾病的存在，對胃腸道內視鏡狹窄治療設備的需求不斷增加。發病率。 此外，在2024 年至2030 年的預測期內，對微創治療設備的需求不斷增加、胃腸道疾病的危險因素增加、老年人口迅速增長、設備技術的進步以及產品批准和上市的增加預計將會增加。胃腸內視鏡狹窄治療設備市場的整體成長

胃腸內視鏡狹窄治療器材市場動態

根據 GLOBOCAN (2021) 的數據，2020 年全球報告了近 604,100 例食道癌新病例。 根據同一數據，2020年，全球報告新發胃癌病例1,089,103例，新發膽道癌病例115,949例。

此外，研究表明，在安寧療護和新輔助治療中，支架置入作為一種胃腸道內視鏡狹窄處理裝置，對於緩解食道、胃十二指腸和大腸的阻塞症狀極為重要。 因此，內視鏡插入自膨式金屬支架（SEMS）是治療胃腸道（GIT）惡性阻塞和狹窄的前沿應用，推動市場成長。

此外，根據國際胃腸道疾病基金會提供的最新研究，估計全球有5-10%的人口受到腸躁症（IBS）的影響。 大多數 IBS 患者年齡在 50 歲以下。 此外，大約三分之二的腸躁症患者是女性，大約三分之一的人是男性。 IBS 盛行率的增加可導致狹窄疾病，可透過胃腸道內視鏡狹窄管理裝置進行治療。

因此，各種胃腸道疾病的盛行率不斷增加，導致狹窄損傷，進而增加了對胃腸道內視鏡狹窄治療設備的需求，推動了預測期內胃腸道內視鏡狹窄治療設備市場的成長。

支架和擴張裝置還能有效擴張和保護胃腸壁。 這些設備併發症發生率低，技術成功率高，可提高病患的生活品質。 這些設備也可以作為侵入性手術的有前途的替代品。 與傳統手術相比，微創手術採用尖端技術，透過小切口進入內臟器官，進而減少疼痛、降低感染風險、縮短住院時間、恢復更快、疤痕更少、只有輕微出血。 因此，預計全球市場在預測期內將受到這些變數的推動。 因此，上述因素將在 2024-2030 年預測期內推動整個胃腸道內視鏡狹窄治療設備市場。

然而，胃腸內視鏡狹窄治療設備市場的成長可能會受到與管理設備、外科手術相關的副作用以及執行外科手術的醫療專業人員短缺的限制。

在 COVID-19 大流行期間，胃腸道內視鏡狹窄管理設備市場受到了重大影響。 這是因為由於大流行的爆發，門診被取消，非緊急住院治療、診斷和外科手術也被停止。 結果，常規實驗室測試、診斷和外科手術減少了。 然而，隨著COVID-19疫苗的研發，封鎖規定的放鬆和經濟情勢的正常化，門診診療等正常醫療服務的恢復，胃腸內視鏡狹窄管理設備市場的產品需求正在增加步入正軌。

胃腸內視鏡狹窄管理器械細分市場分析

在胃腸道內視鏡狹窄管理設備市場的類型細分市場中，生殖健康類別預計將在 2023 年獲得可觀的收入份額。 這可能是由於全球胃腸道疾病的盛行率不斷增加以及支架所帶來的好處。 支架是一種靈活的、自膨脹的中空金屬或塑膠管，用於疏通胃腸道 (GI) 堵塞引起的堵塞。

本報告研究和分析了全球胃腸內視鏡狹窄治療設備市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章胃腸內視鏡狹窄管理器材市場報告簡介

第2章胃腸內視鏡狹窄治療設備市場摘要

• 調查範圍
• 市場概覽
• 競爭評估

第3章監理分析

• 美國
• 歐洲
• 日本
• 中國

第4章胃腸內視鏡狹窄治療器材市場主要因素分析

• 胃腸內視鏡狹窄治療設備市場驅動因素
  • 胃腸道疾病盛行率不斷上升
  • 對微創手術的偏好日益增加
  • 老年人口的增加與食道運動障礙和唾液分泌減少有關
• 胃腸內視鏡狹窄治療器材市場的抑制因素與挑戰
  • 與管理設備和外科手術相關的副作用
  • 缺乏外科手術的醫護人員
• 胃腸內視鏡狹窄處理設備市場機會
  • 不斷增強的技術優勢，例如自膨脹式鎳鈦合金支架

第5章胃腸內視鏡狹窄管理器材市場波特五力分析

第6章胃腸內視鏡狹窄管理器材市場佈局

• 依類型
  • 球囊擴張器
  • 支架
  • 探條擴張器
  • 其他
• 按最終用戶
  • 醫院、診所
  • 門診手術中心
• 按地區
  • 北美胃腸內視鏡狹窄治療設備市場規模（2021-2030）
  • 歐洲胃腸內視鏡狹窄治療設備市場規模（2021-2030）
  • 亞太地區胃腸內視鏡狹窄治療設備市場規模（2021-2030）
  • 其他地區胃腸內視鏡狹窄治療器材市場規模（2021-2030年）

第7章胃腸內視鏡狹窄治療設備市場公司與產品概況

• Boston Scientific Corporation
• Cook
• Olympus
• HOBBS MEDICAL INC.
• Merit Medical Systems
• CONMED Corporation
• Medi-Globe GmbH
• Teleflex Incorporated
• Ovesco Endoscopy AG
• Richard Wolf GmbH
• ZAVATION
• Laborie.
• Micro-Tech Endoscopy

第8章KOL瀏覽量

第 9 章專案方法

第 10 章關於 DelveInsight

第 11 章免責聲明與聯絡我們

Gastrointestinal Endoscopic Stricture Management Device Market By Type (Balloon Dilator, Stents, Bougie Dilator, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of various gastrointestinal disorders and the surging demand of minimally invasive treatment approach across the globe

The global gastrointestinal endoscopic stricture management device market is estimated to grow at a CAGR of 5.36% during the forecast period from 2024 to 2030. The demand for gastrointestinal endoscopic stricture management devices is being boosted by the increasing prevalence of various gastrointestinal (GI) disorders such as colon cancer, rectal cancer, esophageal cancer, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and other. Further, the rising demand for minimally invasive treatment devices, rising figures of GI disorder-causing risk factors, surging geriatric population base, technological advancements about the device, and rising product approvals and launches, among others are thereby contributing to the overall growth of the gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030.

Gastrointestinal Endoscopic Stricture Management Device Market Dynamics:

As per GLOBOCAN 2021, in 2020, nearly 604,100 new cases of oesophageal cancer were reported globally. The same source stated that in 2020, 1,089,103 new cases of stomach cancer and 115,949 new cases of biliary cancer were reported, globally.

In addition, various studies show that in palliative and neoadjuvant settings, stenting, a type of gastrointestinal endoscopic stricture management device is crucial in alleviating esophageal, gastroduodenal, or colorectal obstruction symptoms. Thus, the endoscopic insertion of self-expanding metal stents (SEMSs) has a frontline application for managing malignant obstruction or stricture of the gastrointestinal tract (GIT) driving the market growth.

Further, the latest study provided by International Foundation for Gastrointestinal Disorders, estimated that irritable bowel syndrome (IBS) affects 5-10% of the worldwide population. Most persons with IBS are under the age of 50. Also, about 2 in 3 IBS sufferers are female and about 1 in 3 IBS sufferers are male. The increasing prevalence of IBS can lead to stricture damage which can be treated by gastrointestinal endoscopic stricture management devices.

Therefore, the increasing prevalence of various GI disorders will lead to stricture damage, ultimately increasing the demand for gastrointestinal endoscopic stricture management devices, thereby driving the market for gastrointestinal endoscopic stricture management devices during the forecast period.

Also, stents and dilation devices effectively dilate and protect the gastrointestinal wall. The low complication rates and great technical success of these devices improve patient quality of life. These gadgets also function as successful alternatives to invasive procedures. When compared to traditional surgeries, minimally invasive procedures use cutting-edge technology to access internal organs through tiny incisions, resulting in less pain, a low risk of infection, a shorter hospital stay, a speedier recovery, less scarring, and less blood loss. Thus, the global market is probably going to be driven by these variables during the forecast period. Therefore, the aforementioned factors will propel the overall market of gastrointestinal endoscopic stricture management devices during the forecast period from 2024-2030.

However, side effects related to management devices or surgical procedures, scarcity of healthcare experts to perform surgical procedures, and others may restrict the gastrointestinal endoscopic stricture management device market growth.

The gastrointestinal endoscopic stricture management device market was significantly impacted during the period of COVID- 19 pandemic as the outbreak led to the cancellation of outpatient visits and the suspension of non-emergency hospitalization, diagnostic, and surgical procedures. This resulted in a reduced number of routine clinical examinations, diagnoses, and surgical procedures. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits for diagnosis and treatment purposes, thereby bringing the demand for products on track in the gastrointestinal endoscopic stricture management device market.

Gastrointestinal Endoscopic Stricture Management Device Market Segment Analysis:

Gastrointestinal endoscopic stricture management device market by Type (Balloon Dilator, Stents, Bougie Dilator, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the gastrointestinal endoscopic stricture management device market, the reproductive health category is expected to amass a significant revenue share in the year 2023. This can be attributed to the increasing prevalence of GI diseases globally and the advantages the stents provide. A stent is a flexible, self-expandable, hollow metal or plastic tube used to help open any obstruction in the gastrointestinal (GI) tract that is blocked because of any clog formation.

Corrosive upper gastrointestinal strictures (GIS) are common in children, and primarily accidental ingestion, commonly in younger children, contributes to the GIS. In these cases, stents are used. According to various research, resistant caustic strictures are the most common indication of stent placement in children. In most cases, stents can be utilized along with endoscopic dilatation.

Further, the technological advancements in the stents for better outcomes are anticipated to contribute to the segment's growth. For instance, in February 2022, Micro-Tech Endoscopy introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System's nitinol self-expanding construction and simplicity of use make it efficient at relieving patients with malignant tracheobronchial strictures.

Therefore, the aforementioned factors are predicted to contribute to the increasing demand for this segment thereby driving the growth of the overall gastrointestinal endoscopic stricture management device market during the forecast period.

North America is expected to dominate the overall Gastrointestinal Endoscopic Stricture Management Device Market:

Among all the regions, North America is estimated to account for the largest share of the global gastrointestinal endoscopic stricture management device market in the year 2023. Owing to the factors such as the rising prevalence of gastrointestinal (GI) diseases which lead to increased research & development and manufacturing of numerous devices in the region. Furthermore, high disposable income, sophisticated healthcare infrastructure, and high awareness also helped the market growth in the country.

As per the 2023 report of the American Cancer Society, 106,970 new cases of colon cancer and 46,0850 new cases of rectal cancer are expected to be diagnosed in 2023. Also, as per the same source, about 21,560 new esophageal cancer cases will be diagnosed (17,030 in men and 4,530 in women), in the US, in 2023.

In addition, as per the 2021 report of the International Foundation for Gastrointestinal Disorders (IFFGD), 25 to 45 million people were affected by irritable bowel syndrome in the United States, in 2021.

These gastrointestinal diseases are responsible for strictures in the GI tract, creating the availability of stricture management devices. As gastrointestinal endoscopic stricture management devices, such as balloon dilators, stents, and bougie dilators, provide better outcomes, the need for such devices is increasing in the United States.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, investments, and others also help in boosting regional product demand. For instance, in February 2022, Micro-Tech Endoscopy, a US-based manufacturer, introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System's nitinol self-expanding construction and simplicity of use make it efficient at relieving patients with malignant tracheobronchial strictures. Thus, such strategic steps help to increase the demand for gastrointestinal endoscopic stricture management devices, thereby driving the North America gastrointestinal endoscopic stricture management device market forward during the forecast period.

Gastrointestinal Endoscopic Stricture Management Device Market Key Players:

Some of the key market players operating in the gastrointestinal endoscopic stricture management device market include Boston Scientific Corporation, Cook, Olympus, HOBBS MEDICAL INC., Merit Medical Systems, CONMED Corporation, Medi-Globe GmbH, Teleflex Incorporated, Ovesco Endoscopy AG, Richard Wolf GmbH, ZAVATION, Laborie., Micro-Tech Endoscopy, and others.

Recent Developmental Activities in the Gastrointestinal Endoscopic Stricture Management Device Market:

In June 2022, Boston Scientific Corporation entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64%) of M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech is the creator of the HANAROSTENT technology, a family of conformable, non-vascular, self-expanding metal stents, which Boston Scientific has distributed in Japan since 2015.

In October 2021, Boston Scientific Corporation received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix(TM) Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system.

Key Takeaways from the Gastrointestinal Endoscopic Stricture Management Device Market Report Study

Market size analysis for current gastrointestinal endoscopic stricture management device market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global gastrointestinal endoscopic stricture management device market.

Various opportunities available for the other competitor in the gastrointestinal endoscopic stricture management device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current gastrointestinal endoscopic stricture management device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for gastrointestinal endoscopic stricture management device market growth in the coming future?

Target Audience who can be benefited from this Gastrointestinal Endoscopic Stricture Management Device Market Report Study

Gastrointestinal endoscopic stricture management device products providers

Research organizations and consulting companies

Gastrointestinal endoscopic stricture management device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in the gastrointestinal endoscopic stricture management device

Various End-users who want to know more about the gastrointestinal endoscopic stricture management device market and the latest technological developments in the gastrointestinal endoscopic stricture management device market.

Frequently Asked Questions for the Gastrointestinal Endoscopic Stricture Management Device Market:

1. What is a gastrointestinal endoscopic stricture management device?

Gastrointestinal endoscopic stricture refers to an abnormal narrowing or blocking of sections of the GI tract due to the presence of a tumor or a scar. These strictures are usually treated with endoscopy, a minimally invasive medical method to investigate and operate procedures without making large incisions with the help of various dilation devices and stents.

2. What is the market for global gastrointestinal endoscopic stricture management devices?

The global gastrointestinal endoscopic stricture management device market is estimated to grow at a CAGR of 5.36% during the forecast period from 2024 to 2030.

3. What are the drivers for the global gastrointestinal endoscopic stricture management device market?

The demand for gastrointestinal endoscopic stricture management devices is primarily being heightened by the surging statistics of various GI disorders, increasing risk factors, increasing preference for minimally invasive procedures, rising geriatric population associated with disturbances in esophageal motility and a decreased production of saliva, surging product approvals and launches, among others, thereby contribute to the overall growth of the gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030.

4. Who are the key players operating in the global gastrointestinal endoscopic stricture management device market?

Some of the key market players operating in the gastrointestinal endoscopic stricture management device market include Boston Scientific Corporation, Cook, Olympus, HOBBS MEDICAL INC., Merit Medical Systems, CONMED Corporation, Medi-Globe GmbH, Teleflex Incorporated, Ovesco Endoscopy AG, Richard Wolf GmbH, ZAVATION, Laborie., Micro-Tech Endoscopy, and others.

5. Which region has the highest share in the gastrointestinal endoscopic stricture management device market?

North America is expected to dominate the overall gastrointestinal endoscopic stricture management device market during the forecast period from 2024-2030. Factors such as the rising prevalence of GI disorders, increasing geriatric population, and rising demand for minimally invasive treatment approaches, among the target population, among others will positively impact the North American gastrointestinal endoscopic stricture management device market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about GI disorders also helped the market growth in this region.

Table of Contents

1.Gastrointestinal Endoscopic Stricture Management Device Market Report Introduction

2. Gastrointestinal Endoscopic Stricture Management Device Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Gastrointestinal Endoscopic Stricture Management Device Market Key Factors Analysis

• 4.1. Gastrointestinal Endoscopic Stricture Management Device Market Drivers
  • 4.1.1. Rising prevalence of GI disorders
  • 4.1.2. Increasing preference for minimally invasive procedures
  • 4.1.3. The rising geriatric population is associated with disturbances in esophageal motility and a decreased production of saliva
• 4.2. Gastrointestinal Endoscopic Stricture Management Device Market Restraints and Challenges
  • 4.2.1. Side effects related to management devices or surgical procedures
  • 4.2.2. Scarcity of healthcare experts to perform surgical procedures
• 4.3. Gastrointestinal Endoscopic Stricture Management Device Market Opportunities
  • 4.3.1. Increasing technological advantages such as self-expanding nitinol stent among other

5. Gastrointestinal Endoscopic Stricture Management Device Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Gastrointestinal Endoscopic Stricture Management Device Market Layout

• 6.1. By Type
  • 6.1.1. Balloon Dilator
  • 6.1.2. Stents
  • 6.1.3. Bougie Dilator
  • 6.1.4. Others
• 6.2. By End-User
  • 6.2.1. Hospitals & Clinics
  • 6.2.2. Ambulatory Surgical Centers
  • 6.2.3. Others
• 6.3. By Geography
  • 6.3.1. North America Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.1.1. United States Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.1.2. Canada Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.1.3. Mexico Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
  • 6.3.2. Europe Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.1. France Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.2. Germany Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.3. United Kingdom Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.4. Italy Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.5. Spain Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.2.6. Rest of Europe Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
  • 6.3.3. Asia-Pacific Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.1. China Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.2. Japan Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.3. India Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.4. Australia Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.5. South Korea Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.3.6. Rest of the Asia-Pacific Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
  • 6.3.4. Rest of the World (RoW) Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4.1. Middle East Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4.2. Africa Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)
    • 6.3.4.3. South America Gastrointestinal Endoscopic Stricture Management Device Market Size in USD million (2021-2030)

7. Gastrointestinal Endoscopic Stricture Management Device Market Company and Product Profiles

• 7.1. Boston Scientific Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Cook
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Olympus
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. HOBBS MEDICAL INC.
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Merit Medical Systems
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. CONMED Corporation
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Medi-Globe GmbH
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Teleflex Incorporated
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Ovesco Endoscopy AG
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Richard Wolf GmbH
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. ZAVATION
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Laborie.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Micro-Tech Endoscopy
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

• Table 1: Competitive Analysis
• Table 2: Gastrointestinal Endoscopic Stricture Management Device Market in Global (2021-2030)
• Table 3: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Type (2021-2030)
• Table 4: Gastrointestinal Endoscopic Stricture Management Device Market in Global by End-User (2021-2030)
• Table 5: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Geography (2021-2030)
• Table 6: Gastrointestinal Endoscopic Stricture Management Device Market in North America (2021-2030)
• Table 7: Gastrointestinal Endoscopic Stricture Management Device Market in North America by Country (2021-2030)
• Table 8: Gastrointestinal Endoscopic Stricture Management Device Market in the US (2021-2030)
• Table 9: Gastrointestinal Endoscopic Stricture Management Device Market in Canada (2021-2030)
• Table 10: Gastrointestinal Endoscopic Stricture Management Device Market in Mexico (2021-2030)
• Table 11: Gastrointestinal Endoscopic Stricture Management Device Market in Europe (2021-2030)
• Table 12: Gastrointestinal Endoscopic Stricture Management Device Market in Europe by Country (2021-2030)
• Table 13: Gastrointestinal Endoscopic Stricture Management Device Market in France (2021-2030)
• Table 14: Gastrointestinal Endoscopic Stricture Management Device Market in Germany (2021-2030)
• Table 15: Gastrointestinal Endoscopic Stricture Management Device Market in the United Kingdom (2021-2030)
• Table 16: Gastrointestinal Endoscopic Stricture Management Device Market in Italy (2021-2030)
• Table 17: Gastrointestinal Endoscopic Stricture Management Device Market in Spain (2021-2030)
• Table 18: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of Europe (2021-2030)
• Table 19: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific (2021-2030)
• Table 20: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific by Country (2021-2030)
• Table 21: Gastrointestinal Endoscopic Stricture Management Device Market in China (2021-2030)
• Table 22: Gastrointestinal Endoscopic Stricture Management Device Market in Japan (2021-2030)
• Table 23: Gastrointestinal Endoscopic Stricture Management Device Market in India (2021-2030)
• Table 24: Gastrointestinal Endoscopic Stricture Management Device Market in Australia (2021-2030)
• Table 25: Gastrointestinal Endoscopic Stricture Management Device Market in South Korea (2021-2030)
• Table 26: Gastrointestinal Endoscopic Stricture Management Device Market in Rest of Asia-Pacific (2021-2030)
• Table 27: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of the World (2021-2030)
• Table 28: Gastrointestinal Endoscopic Stricture Management Device Market in RoW by Region (2021-2030)
• Table 29: Gastrointestinal Endoscopic Stricture Management Device Market in the Middle East (2021-2030)
• Table 30: Gastrointestinal Endoscopic Stricture Management Device Market in Africa (2021-2030)
• Table 31: Gastrointestinal Endoscopic Stricture Management Device Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Gastrointestinal Endoscopic Stricture Management Device Market in Global (2021-2030)
• Figure 3: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Type (2021-2030)
• Figure 4: Gastrointestinal Endoscopic Stricture Management Device Market in Global by End-User (2021-2030)
• Figure 5: Gastrointestinal Endoscopic Stricture Management Device Market in Global by Geography (2021-2030)
• Figure 6: Gastrointestinal Endoscopic Stricture Management Device Market in North America (2021-2030)
• Figure 7: Gastrointestinal Endoscopic Stricture Management Device Market in North America by Country (2021-2030)
• Figure 8: Gastrointestinal Endoscopic Stricture Management Device Market in the US (2021-2030)
• Figure 9: Gastrointestinal Endoscopic Stricture Management Device Market in Canada (2021-2030)
• Figure 10: Gastrointestinal Endoscopic Stricture Management Device Market in Mexico (2021-2030)
• Figure 11: Gastrointestinal Endoscopic Stricture Management Device Market in Europe (2021-2030)
• Figure 12: Gastrointestinal Endoscopic Stricture Management Device Market in Europe by Country (2021-2030)
• Figure 13: Gastrointestinal Endoscopic Stricture Management Device Market in France (2021-2030)
• Figure 14: Gastrointestinal Endoscopic Stricture Management Device Market in Germany (2021-2030)
• Figure 15: Gastrointestinal Endoscopic Stricture Management Device Market in the United Kingdom (2021-2030)
• Figure 16: Gastrointestinal Endoscopic Stricture Management Device Market in Italy (2021-2030)
• Figure 17: Gastrointestinal Endoscopic Stricture Management Device Market in Spain (2021-2030)
• Figure 18: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of Europe (2021-2030)
• Figure 19: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific (2021-2030)
• Figure 20: Gastrointestinal Endoscopic Stricture Management Device Market in Asia-Pacific by Country (2021-2030)
• Figure 21: Gastrointestinal Endoscopic Stricture Management Device Market in China (2021-2030)
• Figure 22: Gastrointestinal Endoscopic Stricture Management Device Market in Japan (2021-2030)
• Figure 23: Gastrointestinal Endoscopic Stricture Management Device Market in India (2021-2030)
• Figure 24: Gastrointestinal Endoscopic Stricture Management Device Market in Australia (2021-2030)
• Figure 25: Gastrointestinal Endoscopic Stricture Management Device Market in South Korea (2021-2030)
• Figure 26: Gastrointestinal Endoscopic Stricture Management Device Market in Rest of Asia-Pacific (2021-2030)
• Figure 27: Gastrointestinal Endoscopic Stricture Management Device Market in the Rest of the World (2021-2030)
• Figure 28: Gastrointestinal Endoscopic Stricture Management Device Market in RoW by Region (2021-2030)
• Figure 29: Gastrointestinal Endoscopic Stricture Management Device Market in the Middle East (2021-2030)
• Figure 30: Gastrointestinal Endoscopic Stricture Management Device Market in Africa (2021-2030)
• Figure 31: Gastrointestinal Endoscopic Stricture Management Device Market in South America (2021-2030)
• Figure 32: Market Drivers
• Figure 33: Market Barriers
• Figure 34: Marker Opportunities
• Figure 35: PORTER'S Five Force Analysis